Feds Powell Vows No Shadow Chair Role but Warsh Dynamics May Complicate Meetings NASA Taps Blue Origin for First of Three Uncrewed Lunar Missions as 20 Billion Moon Base Plans Take Shape BJs Wholesale Club Delivers Q1 Fiscal 2026 Results Membership and Traffic Trends in Focus Dow Leads as Defensive Sectors Outperform Tech Lags IBM Surges on Trump Administrations 2 Billion Quantum Computing Initiative Energy Transfer EBITDA Outlook Strengthens Analyst Lifts Price Target DHX Q1 2026 Earnings EPS Smashes Estimates by 164 as Tech Hiring Platform Shows Resilience A10 Networks Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction NextPlat Corp NXPL Q1 2026 Earnings Loss Widens as Growth Initiatives Weigh on Bottom Line BBU Q4 2025 Earnings Significant Earnings Miss Impacts Quarterly Results Innovative Eyewear Inc LUCY Q1 2026 Earnings Narrowing Losses Lift Sentiment RXST Q1 2026 Earnings EPS Misses Estimates Amid Ongoing RampUp Central Garden Pet CENTA Slips 087 Navigating Resistance and Sector Headwinds Fortress Biotech Preferred FBIOP Gains 121 as Income Seekers Eye 9375 Yield Wintergreen Acquisition Corp WTG Holds Steady Near Trust Value Amid Low Volume EZCORP Inc EZPW Faces Pressure Shares Decline Over 4 as Key Support Test Looms Eastman Chemical EMN Edges Higher as Support Holds Resistance in Sight Nio Shares Surge 9 After Launch of ES9 SUV First Major New Model in Over Two Years Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment The Pitfalls of Performance Chasing Why LongTerm Strategy Matters Over ShortTerm Returns Rubios NATO Reassurance Amidst Shifting US Troop Plans Geopolitical Signals and Defense Market Implications Deutsche Bank Maintains Positive Stance on Salesforce Amid Citi Price Target Revision Jim Cramer Advises Holding Astera Labs Shares Amid Market Uncertainty SEBI Bars Seven Family Members in Social Media PumpandDump Case Alleges 2025 Crore Illegal Gains CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support